COMMUNIQUÉS West-GlobeNewswire

Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference

06/03/2019 - 14:00

CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference

06/03/2019 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., March 06, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference

06/03/2019 - 14:00

CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating [...]

Mesa Labs Announces Changes in The Composition of Its Board of Directors

06/03/2019 - 14:00

LAKEWOOD, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) has announced several changes to the composition of its Board of Directors (the “Board”). [...]

miRagen Therapeutics to Present a Corporate Overview at the 29th Annual Oppenheimer & Co. Healthcare Conference

06/03/2019 - 14:00

BOULDER, Colo., March 06, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced [...]

Catalyst Biosciences Announces Poster Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting

06/03/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]

MyoKardia to Present at Cowen & Co. 39th Annual Health Care Conference

06/03/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of serious cardiovascular [...]

Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters

06/03/2019 - 14:00

New facility expected to meet all clinical and commercial development needs of lead program KB103 A second, larger cGMP facility expected to be completed in 2020 to meet all anticipated future pipeline production [...]

Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma

06/03/2019 - 14:00

Presented at the World Immunotherapy Congress USA 2019 SYDNEY, Australia, March 06, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel [...]

Cabaletta Bio to Present at the Cowen and Company 39th Annual Healthcare Conference

06/03/2019 - 14:00

RADNOR, Pa., March 06, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a biotechnology company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases, today announced that [...]

PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference

06/03/2019 - 14:00

MALVERN, Pa. and SAN DIEGO, March 06, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel [...]

Biotricity Achieves Significant Milestones for Both Fetal/Maternal and Ambulatory Wellness Monitoring Systems

06/03/2019 - 14:00

Hospital-based R&D Program Underway and Generating Measurable Clinical Data REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Biotricity , Inc. (OTCQB: BTCY ), a medical diagnostic and consumer healthcare [...]

Misonix To Present At The 9th Annual Canaccord Genuity Musculoskeletal Conference On March 12

06/03/2019 - 14:00

FARMINGDALE, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

GBT Announces New Employment Inducement Grants

06/03/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2019, the compensation committee of GBT’s board of directors granted [...]

Jounce Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

06/03/2019 - 12:30

- New data from two programs to be presented at AACR - - New Phase 2 studies to be initiated in 2019 supported by established safety from dose escalation cohorts of vopratelimab (JTX-2011), with ipilimumab and with [...]

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2019

06/03/2019 - 12:30

OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the [...]

Tetra Bio-Pharma Names Vice-President, Clinical Programs and Medical Affairs to Its Leadership Team

06/03/2019 - 12:30

Dr. Aurelia De Pauw to Oversee Clinical Operations ORLEANS, Ontario, March 06, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in [...]

ViroGates announces launch of suPARnostic® TurbiLatex for the Roche cobas c 502 module

06/03/2019 - 12:23

Company announcement no. 1-2019 Birkerød, 6 March 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today announces that it has [...]

Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism

06/03/2019 - 09:00

Press Release – No. 05/2019 Zealand Pharma doses first patient in Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism Congenital hyperinsulinism (CHI) is a rare pediatric disease with high [...]